Edition:
India

Taro Pharmaceutical Industries Ltd (TARO.N)

TARO.N on New York Stock Exchange

107.38USD
19 Oct 2017
Change (% chg)

$1.81 (+1.71%)
Prev Close
$105.57
Open
$105.78
Day's High
$107.38
Day's Low
$105.69
Volume
4,816
Avg. Vol
18,505
52-wk High
$124.31
52-wk Low
$92.28

Chart for

About

Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc. (Taro Canada) and Taro U.S.A. The Company markets over 200 pharmaceutical... (more)

Overall

Beta: 0.66
Market Cap(Mil.): $4,626.61
Shares Outstanding(Mil.): 40.51
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 30.44 16.24
EPS (TTM): -- -- --
ROI: -- 14.17 10.90
ROE: -- 15.52 14.09

BRIEF-Taro announces joining of CEO

* Taro Pharmaceutical Industries Ltd - ‍ Uday Baldota has joined company as its chief executive officer ("CEO") effective August 28, 2017​

02 Sep 2017

Indian shrs fall for 3rd day; US-N.Korea tensions spook investors

Aug 9 Indian shares fell for a third consecutive session on Wednesday, dragged down by financial and healthcare stocks, as escalating tensions on the Korean peninsula hit regional markets.

09 Aug 2017

BUZZ-India's Sun Pharma falls to over 4-yr low

** Sun Pharmaceutical Industries' shares slump as much as 5 pct to lowest since June 2013

09 Aug 2017

BRIEF-Taro reports quarterly net income per ordinary share $1.35

* Qtrly net income per ordinary share $1.35 Source text for Eikon: Further company coverage:

09 Aug 2017

BUZZ-Taro Pharmaceutical: Shares down after Q4 revenue miss

** Generic drug maker's shares fall as much as 5.9 pct to $105.70; biggest intraday pct drop in more than 5 months

23 May 2017

BRIEF-Taro reports qtrly EPS $2.05

* Qtrly earnings per share $2.05 Source text for Eikon: Further company coverage:

23 May 2017

BRIEF-Crescita Therapeutics announces agreement with Taro Pharmaceuticals for Pliaglis

* Crescita Therapeutics announces agreement with Taro Pharmaceuticals for Pliaglis

25 Apr 2017

Earnings vs. Estimates